Treatment re-sensitizes both neutrophils and macrophages to LPS, with treated cells releasing significantly higher levels of pro inflammatory cytokines including TNF-α, IL-6, and IL-8, all of which are released at significantly lower levels in many patients during the later stages of sepsis (Mathias et al., 2015). Here, TNF is linked to Sepsis.